SEC Filing Summary: Xcyte Therapies, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Xcyte Therapies, Inc., a Delaware corporation, on February 2, 2005, covering events occurring on January 28, 2005. The registrant is headquartered in Seattle, Washington.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements.
Material Changes
Effective January 28, 2005, Dennis Henner, Ph.D., resigned from the Registrant's Board of Directors. The filing explicitly states that this resignation did not involve any disagreement with the Registrant.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific event of the director's departure.
Investor Verification Checklist
- Verify the composition of the Board of Directors following Dr. Henner's resignation.
- Confirm whether a replacement director was appointed to fill the vacancy.
- Review subsequent filings for any undisclosed disagreements or related party transactions involving the departing director.